Table 6.
Maternal outcomes in the intervention and control groups.
| Intervention | Control | OR (95%CI) Intervention/Control | p | |
|---|---|---|---|---|
| Excessive GWG n (%) | 16 (40.0) | 17 (39.5) | 1.02 (0.42–2.45) | 0.5 |
| GDM n (%) | 8 (21.6) | 4 (10.3) | 2.41 (0.66–8.83) | 0.1 |
| Fasting plasma glucose (g/l) | Group: 0.04; Time: 0.6 Group*time: 0.3 |
|||
| Trimester 1 | 0.77 ± 0.05 | 0.76 ± 0.06 | ||
| Trimester 2 | 0.80 ± 0.08 | 0.76 ± 0.06 | ||
| Trimester 3 | 0.79 ± 0.09 | 0.76 ± 0.06 | ||
| OGTT (g/l) | Group: 0.5; Time: <0.001 Group*time: 0.3 |
|||
| T0 | 0.80 ± 0.08 1.23 ± 0.29 |
0.76 ± 0.06 1.25 ± 0.23 |
||
| T60 | ||||
| T120 | 1.15 ± 0.28 | 1.10 ± 0.20 | ||
| Area under the curve (AUC) | 204 ± 42 | 201 ± 32 | 0.7 | |
| Maternal hypertension during labor, n/% | 7 (16.3) | 9 (21.4) | 0.71 (0.23–2.13) | 0.3 |
| Cesarean | 7 (15.9) | 6 (12.5) | 0.75 (0.23–2.44) | 0.4 |
Glycemia data are reported in mean and standard deviation (SD). Data on excessive gestational weight gain (GWG): n = 40 and 43 for the intervention and control groups, respectively. Data on gestational diabetes, glycemia values: n = 37 and 39 for the intervention and control groups, respectively. Cesarean data: n = 44 and 48 for the intervention and control groups, respectively. Maternal hypertension data: n = 43 and 42 for the intervention and control groups, respectively. (Odds Ratio (OR); Confidence Interval (CI). * Group-by-time = interaction.